Adjunctive Use of Statins for COVID-19
The interaction between obesity, cardiometabolic disorders and COVID-19 represents a syndemic that requires both social intervention and a multipharmacological approach [...]
Main Authors: | Mike Sathekge, Geert Byttebier, Bart De Spiegeleer, Bo Saxberg, Veronica Ueckermann, Luc Belmans, Myriam Alexander, David Fedson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/7/1407 |
Similar Items
-
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
by: Geert Byttebier, et al.
Published: (2021-09-01) -
Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful?
by: Bruno Mégarbane
Published: (2022-10-01) -
Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review
by: Anne-Leen Deleu, et al.
Published: (2020-08-01) -
N-acetylcysteine as an adjunct treatment of schizophrenia
by: R. Mota Freitas, et al.
Published: (2021-04-01) -
Treating COVID-19: Targeting the Host Response, Not the Virus
by: David S. Fedson
Published: (2023-03-01)